Several contradictory reports have appeared concerning antibiotic production by myxococci and their possible role in predation by the myxobacteria (3). Oxford (11) reported that Myxococcus virescens excretes antibiotics into the medium during the end of the exponential growth phase. However, he was unable to purify the antibiotic(s) because of its apparent instability. Noren (9) was unable to repeat these observations, but he was able to provide evidence that M. virescens produces an antibiotic against Aerobacter aerogenes. In a later publication Noren and Raper (10) reported that fruiting myxobacteria produced antibiotics active against all gram-positive bacteria tested but none against gram-negative bacteria. On the other hand, Kletter and Henis (4) were unable to detect any antibiotic activity against gram-positive or gram-negative bacteria in cellfree filtrates of M. fulvus and M. virescens, and Margalith (8) was also unable to demonstrate antibiotic activity of M. fulvus against Escherichia coli. Since in none of these investigations was the antibiotic isolated, it is difficult to assess how much of the reported phenomena was due to antibiotic and how much to other factors, such as bacteriolytic enzymes (15).
Myxococcus xanthus produced an antibiotic during the end of its exponential growth phase which was capable of inhibiting growth of several gram-positive and gram-negative bacteria. The antibiotic was bactericidal to growing cultures only; chloramphenicol inhibited the bactericidal action of the antibiotic. Upon addition of the antibiotic to Escherichia coli B, deoxyribonucleic acid and ribonucleic acid as well as turbidity of the culture continued to increase even after the viable count decreased; the culture lysed about 60 min after addition of sufficient concentrations of the antibiotic. Spheroplasts could be prepared if the antibiotic was added to a culture growing in the presence of high concentrations of sucrose and MgSO4. Mutants of M. xanthus FB which are incapable of fruiting body formation or glycerol-induced myxospore formation also produced the antibiotic. A mutant of E. coli resistant to the purified antibiotic was isolated in order to study the role of the antibiotic in the predatory behavior of myxococci.
Several contradictory reports have appeared concerning antibiotic production by myxococci and their possible role in predation by the myxobacteria (3). Oxford (11) reported that Myxococcus virescens excretes antibiotics into the medium during the end of the exponential growth phase. However, he was unable to purify the antibiotic(s) because of its apparent instability. Noren (9) was unable to repeat these observations, but he was able to provide evidence that M. virescens produces an antibiotic against Aerobacter aerogenes. In a later publication Noren and Raper (10) reported that fruiting myxobacteria produced antibiotics active against all gram-positive bacteria tested but none against gram-negative bacteria. On the other hand, Kletter and Henis (4) were unable to detect any antibiotic activity against gram-positive or gram-negative bacteria in cellfree filtrates of M. fulvus and M. virescens, and Margalith (8) was also unable to demonstrate antibiotic activity of M. fulvus against Escherichia coli. Since in none of these investigations was the antibiotic isolated, it is difficult to assess how much of the reported phenomena was due to antibiotic and how much to other factors, such as bacteriolytic enzymes (15) .
Recently we isolated a strain of Myxococcus xanthus, referred to as M. xanthus TA, which produces a potent and stable antibiotic. The antibiotic was purified over 1,000-fold to apparent homogeneity and was partially characterized chemically. This paper describes experiments which characterize the antibiotic biologically as to: (i) mode of action, (ii) spectrum of antibacterial activity, and (iii) relationship between antibiotic production and the life cycle of M. xanthus.
MATERIALS AND METHODS Bacteria and growth conditions. M. xanthus TA was isolated by standard procedures in this laboratory from the bark of an olive tree (13) . The organism was stored either as fruiting bodies on dead E. coli agar plates (13) or on 0.1% CT agar: 0.1% Casitone (Difco) containing 0.1% MgSO4 and solidified with 1.5% agar (Difco). Unless otherwise specified, all CT media contained 0.1% MgSO4. M. xanthus TA was maintained in liquid culture at 32 C by periodic transfers in 1% CT medium; aeration was achieved with gyratory shaking (350 rpm).
M. xanthus FB and FBmp (17) were grown in 1% CT medium. In order to check for myxospore formation, exponentially growing cultures were induced to form myxospores by the addition of 10 M glycerol to a final concentration of 0.5 M as described previously (1) Antibiotic assay. Antibiotic activity against E. coli B was determined either by a serial dilution assay procedure or by the paper disk assay method (7) . In the serial dilution assay procedure, an overnight culture of E. coli B in nutrient broth was diluted 1: 1,000 into fresh, prewarmed nutrient broth and allowed to incubate with aeration at 37 C for 1 h. This procedure yielded approximately 5 x 106 cells per ml in exponential growth phase. Varying concentrations of the antibiotic in 0.02 M tris(hydroxymethyl)aminomethane buffer, pH 7.2, were then added to the exponentially growing E. coli and incubation continued. After 2 h of exposure to the antibiotic, viable cell number was determined by spreading appropriate dilutions on nutrient agar. One unit of the antibiotic was defined as that quantity which brings about a hundred-fold reduction in the viable cell number per milliliter by this standard assay procedure.
In the paper disk method, varying quantities of a ANTIMICROB. AG. CHEMOTHER.
chloroform solution of the antibiotic were applied to disks (5.5-mm diameter) of Whatman no. 3 MM filter paper and dried at room temperature with a stream of air. The disks were then placed on nutrient agar plates which had been overlaid with 0.5% soft agar containing nutrient broth and 106 E. coli B. The diameter of the zone of inhibition was recorded after 18 h at 37 C. The units of antibiotic activity were determined from a standard inhibition curve. One unit of the antibiotic (determined by the serial dilution assay procedure) yielded a diameter of inhibition of approximately 3 mm (excluding the 5.5-mm disk). An antibacterial spectrum of the antibiotic was obtained by using the paper disk method as described above, except that various test organisms were substituted for E. coli B. In each case case the soft agar was seeded with 101 test organisms. Penicillin (10 U) disks were used as comparative controls.
Purification of antibiotic. Purified antibiotic TA was prepared from 12 liters of culture fluid by the following scheme: (i) extraction into 9 liters of chloroform; (ii) adsorption onto 100 g of activated silicic acid followed by elution with 1 liter of 5% methanol in chloroform; (iii) silicic acid chromatography; (iv) preparative thin-layer chromatography on alumina oxide by using sequentially three different solvent systems: 5% methanol in chloroform, 10% methanol in chloroform, and ethyl acetate:isoproponal:water (65:23.5:11.5, vol/vol/vol). The details of this procedure together with a partial chemical characterization of the purified antibiotic will be published elsewhere.
Kinetics of thymidine and uridine incorporation. Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis were estimated by incorporation of thymidine-methyl-3H (Schwarz BioResearch Inc., Van Nuys, Calif.) and uridine-5-3H (Schwarz BioResearch), respectively, into the cold trichloroacetic acid-insoluble material as described previously (1, 14 
RESULTS
Bactericidal action of M. xanthus TA antibiotic. Figures 1 through 3 demonstrate the bactericidal action of M. xanthus TA antibiotic on exponentially growing E. coli B. With 4 U of antibiotic per ml and 107 E. coli per ml (Fig. 1) , the cells lost their ability to form colonies at an exponential rate, approximately 90% every 45 min. Under these conditions, there were less than 107 survivors after 15 h. The antibiotic killed only growing cells (Fig. 2) . When cells were harvested, washed, placed in buffer for 90 min, and then exposed to the antibiotic, there was no detectable killing. Parallel cultures of 6 VOL. 4 x 106 and 6 x 107 cells per ml in nutrient broth rapidly lost viability. On the other hand, a culture approaching stationary phase (5 x 108 cells per ml) was only slightly affected by 3.5 U of antibiotic per ml. The strong dependence of the bactericidal action on the antibiotic concentration is summarized in Fig. 3 . Below 0.75 U of antibiotic per ml, there was no detectable effect upon the growth of the cells; above 1.25 U/ml, maximal killing was achieved.
Mode of action of M. xanthus TA antibiotic. The observation that the antibiotic was not bactericidal to E. coli when the cells were incubated in buffer rather than nutrient medium was investigated further by use of chloramphenicol (Fig. 4) . With 4.0 U of the M. xanthus TA antibiotic per ml and 8 x 10' E. coli B per ml, 99% of the cells were killed in 30 min. In a parallel experiment supplemented with 23 ,ug of chloramphenicol per ml, it took over 150 min to achieve only a 90% kill. Thus protein synthesis appeared to be required for the rapid bactericidal action of M. xanthus TA antibiotic. Under the conditions used, control flasks containing only chloramphenicol caused approximately 50% killing of E. coli B in 150 min.
Although M. xanthus TA antibiotic caused a rapid killing of E. coli as measured by ability to form colonies on nutrient agar (Fig. 1, 2, and 4 However, more significantly, antibiotic was produced 8 to 24 h after glycerol induction, a time at which the metabolism of the myxospore is greatly reduced. The antibiotics produced by M. xanthus FB and M. xanthus TA appear to be identical because (i) E. coli B mutants resistant to antibiotic TA were also resistant to the antibiotic elucidated by M. xanthus FB, and (ii) they exhibited identical mobilities on alumina oxide thin-layer chromatography using several solvent systems.
The kinetics of antibiotic production on solid medium was examined by inoculating 0.2% CT agar with M. xanthus FB and then periodically M. XANTHUS ANTIBIOTIC 511 cross-streaking with E. coli B and E. coli B (TAr). Antibiotic production coincided with fruiting body formation, beginning at 3 days and reaching a maximum at 5 days. In order to test whether or not fruiting body formation or myxospore formation, or both, were genetically linked to antibiotic production, mutants deficient in these properties were examined (Table  3) . M. xanthus FB caused a partial inhibition of growth of even the antibiotic-resistant mutant, E. coli B (TAr). Presumably, M. xanthus FB excretes factors other than the antibiotic which can also inhibit E. coli B. A mutant derived from M. xanthus FB (M. xanthus FBmp), which has been studied in our laboratory for several years and which has lost the potential to form fruiting bodies but retained the ability to make glycerol-induced myxospores, produced no antibiotic. Several attempts to detect antibiotic production in liquid cultures of M. xanthus FBmp were also unsuccessful. However, several freshly isolated mutants of M. xanthus FB defective in glycerol-induced myxospore formation (MS-) or fruiting body formation (FB-) produced normal levels of antibiotic. and then divided into two parts. One part received the antibiotic at a final concentration of 2.8 U/ml (0), and the control received an equivalent volume of buffer (0). At the times indicated, 0.1-ml samples were withdrawn for determination of trichloroacetic acid-insoluble radioactivity. The M. xanthus TA antibiotic differs in several of its properties from the well-studied antibiotic myxin (2, 5, 6, 13) , which is produced by the myxobacter Soranigium sp. (strain 3C). First, myxin is a wide-spectrum antibiotic, whereas the M. xanthus TA antibiotic exhibits a selective antibacterial spectrum. Second, the primary effect of myxin is the inhibition of DNA synthesis, followed by extensive degradation of intracellular DNA; the M. xanthus TA antibiotic apparently interferes with cell wall biosynthesis. Third, mixtures of the two antibiotics can easily be resolved by thin-layer or paper chromatography (myxin appears to be considerably more polar than the M. xanthus TA antibiotic).
Although M. xanthus TA antibiotic was effective against most of the bacteria tested, considerable quantitative differences in sensitivity were observed. For example, E. coli B and Klebsiella pneumoniae were more sensitive to 2 U (0.24 Ag) than Streptococcus faecalis or Salmonella typhimurium were to 100 U (12 jig). a Isolated colonies of each of the M. xanthus strains were transferred from 2% CT agar to 0.2% CT agar and incubated for 5 days at 32 C. Overnight cultures of E. coli B and the antibiotic-resistant E. coli B (TAM) were then streaked separately up to the edge of the M. xanthus colony. After incubation for an additional 24 h at 37 C, the distance (mm) between the edge of the colony and the beginning of E. coli growth was recorded.
Even different strains of E. coli exhibited varied sensitivities. These data may help to explain some of the contradictory reports on antibiotic activity in culture fluids of Myxococci.
The demonstration of antibiotic production by myxococci is interesting both from the point of view of the biology of myxobacteria and its potential applicability as a therapeutic agent. It should be pointed out that myxococci characteristically grow on solid surfaces, obtaining their nutrients in nature by lysing bacterial cells and utilizing the solubilized products to satisfy all of their growth requirements. Therefore, it was reasonable to suppose that the antibiotic could play a positive role in procuring food. This is not inconsistent with the mode of action of the antibiotic, i.e., lysis of sensitive cells. It is noteworthy, however, that M. xanthus FB produces antibiotic TA at about the same time that fruiting body formation commences and that rich media inhibit both fruiting body and antibiotic formation. This is similar to the often reported phenomenon in other prokaryotic cells that conditions which favor sporulation also stimulate antibiotic production. In M. xanthus, morphogenesis is not essential for antibiotic production since mutants deficient in either glycerol-induced myxospore formation or fruiting body formation still produce antibiotic.
The selective host range spectrum of antibiotic TA, the indication that it works on the bacterial cell wall, the fact that it is heat and acid resistant and is not inactivated by sera, and the fact that penicillin-resistant E. coli is sensitive to antibiotic TA all raise rather interesting possibilities for the potential usefulness of the material as a therapeutic agent. These data together with the almost complete lack of studies concerning antibiotics from myxococci indicate that this may be a fertile field for further investigation.
